Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Niemann-Pick Disease, Type C D052556 1 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Sensation Disorders D012678 2 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Ileus D045823 3 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Fabry Disease D000795 4 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Ovarian Diseases D010049 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Teratocarcinoma D018243 7 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Karliner JS Sphingosine kinase and sphingosine 1-phosphate in cardioprotection. 2009 J. Cardiovasc. Pharmacol. pmid:19247197
Bandhuvula P et al. Sphingosine 1-phosphate lyase enzyme assay using a BODIPY-labeled substrate. 2009 Biochem. Biophys. Res. Commun. pmid:19250638
Hagen N et al. Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons. 2009 J. Biol. Chem. pmid:19251691
Sandhu KS et al. Regional heterogeneity in expression of the sphingosine-1-phosphate pathway in the female rat lower urinary tract. 2009 Am. J. Obstet. Gynecol. pmid:19254791
Valverde O et al. GPR3 receptor, a novel actor in the emotional-like responses. 2009 PLoS ONE pmid:19259266
Kim RH et al. Export and functions of sphingosine-1-phosphate. 2009 Biochim. Biophys. Acta pmid:19268560
Shimizu M et al. Effects of synthetic sphingosine-1-phosphate analogs on cytosolic phospholipase A2alpha-independent release of arachidonic acid and cell toxicity in L929 fibrosarcoma cells: the structure-activity relationship. 2009 J. Pharmacol. Sci. pmid:19276615
Li Y and Yu KL [Advances in thrombin-protease-activated receptor 1-sphingosine 1-phosphate pathway during sepsis]. 2009 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:19278594
Milara J et al. Sphingosine-1-phosphate increases human alveolar epithelial IL-8 secretion, proliferation and neutrophil chemotaxis. 2009 Eur. J. Pharmacol. pmid:19285497
He X et al. Quantitative analysis of sphingosine-1-phosphate by HPLC after napthalene-2,3-dicarboxaldehyde (NDA) derivatization. 2009 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:19285924
Yin H et al. Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. 2009 J. Biol. Chem. pmid:19286662
Boyce BF Sphingosine-1 phosphate: a new player in osteoimmunology. 2009 Dev. Cell pmid:19289077
Yamane D et al. Inhibition of sphingosine kinase by bovine viral diarrhea virus NS3 is crucial for efficient viral replication and cytopathogenesis. 2009 J. Biol. Chem. pmid:19293152
Green DS et al. Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy. 2009 J. Virol. pmid:19297493
Kenagy RD et al. Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. 2009 J. Vasc. Surg. pmid:19307078
Jongsma M et al. Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)). 2009 Br. J. Pharmacol. pmid:19309361
Sali M et al. Exploiting immunotherapy in Mycobacterium tuberculosis-infected mice: sphingosine 1-phosphate treatment results in a protective or detrimental effect depending on the stage of infection. 2009 Jan-Mar Int J Immunopathol Pharmacol pmid:19309565
Sun X et al. Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement. 2009 Microvasc. Res. pmid:19323978
Beech DJ et al. TRPC channel lipid specificity and mechanisms of lipid regulation. 2009 Cell Calcium pmid:19324410
Scherer M et al. High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. 2009 Clin. Chem. pmid:19325012
Hayashi H et al. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19325137
Annabi B et al. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. 2009 Mol. Carcinog. pmid:19326372
Nincheri P et al. Sphingosine 1-phosphate induces differentiation of adipose tissue-derived mesenchymal stem cells towards smooth muscle cells. 2009 Cell. Mol. Life Sci. pmid:19337690
Schulz C et al. Hematopoietic stem and progenitor cells: their mobilization and homing to bone marrow and peripheral tissue. 2009 Immunol. Res. pmid:19340403
Sasaki H et al. pH dependence of sphingosine aggregation. 2009 Biophys. J. pmid:19348755
Straub AC et al. Arsenic requires sphingosine-1-phosphate type 1 receptors to induce angiogenic genes and endothelial cell remodeling. 2009 Am. J. Pathol. pmid:19349368
Rodríguez C et al. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin. 2009 Thromb. Haemost. pmid:19350109
Formigli L et al. Regulation of transient receptor potential canonical channel 1 (TRPC1) by sphingosine 1-phosphate in C2C12 myoblasts and its relevance for a role of mechanotransduction in skeletal muscle differentiation. 2009 J. Cell. Sci. pmid:19351713
Miranda GE et al. Sphingosine-1-phosphate is a key regulator of proliferation and differentiation in retina photoreceptors. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19357361
Hu W et al. Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity. 2009 J. Lipid Res. pmid:19369694
Yu H et al. Roles of extracellular and intracellular sphingosine 1-phosphate in cell migration. 2009 Genes Cells pmid:19371379
Guillermet-Guibert J et al. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. 2009 Mol. Cancer Ther. pmid:19372554
Hendriks-Balk MC et al. Sphingosine-1-phosphate regulates RGS2 and RGS16 mRNA expression in vascular smooth muscle cells. 2009 Eur. J. Pharmacol. pmid:19374869
Ader I et al. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. 2009 Cancer Res. pmid:19383898
Li C et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. 2009 J. Hepatol. pmid:19398237
Guzmán-Hernández ML et al. Differential inhibitor of Gbetagamma signaling to AKT and ERK derived from phosducin-like protein: effect on sphingosine 1-phosphate-induced endothelial cell migration and in vitro angiogenesis. 2009 J. Biol. Chem. pmid:19403526
Hofmann U et al. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion. 2009 Cardiovasc. Res. pmid:19416991
Michaud MD et al. Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19423865
Mullershausen F et al. Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. 2009 Nat. Chem. Biol. pmid:19430484
Tao R et al. Cardiomyocyte S1P1 receptor-mediated extracellular signal-related kinase signaling and desensitization. 2009 J. Cardiovasc. Pharmacol. pmid:19433984
Yang G et al. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19435851
Peyruchaud O Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer. 2009 Anticancer Agents Med Chem pmid:19442039
Li X et al. Fenretinide inhibits myeloma cell growth, osteoclastogenesis and osteoclast viability. 2009 Cancer Lett. pmid:19446953
Chao HH et al. L-Carnitine attenuates angiotensin II-induced proliferation of cardiac fibroblasts: role of NADPH oxidase inhibition and decreased sphingosine-1-phosphate generation. 2010 J. Nutr. Biochem. pmid:19447019
Monier A et al. Horizontal gene transfer of an entire metabolic pathway between a eukaryotic alga and its DNA virus. 2009 Genome Res. pmid:19451591
Chang CL et al. S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells. 2009 Am. J. Physiol., Cell Physiol. pmid:19474291
Schulz C et al. Trafficking of murine hematopoietic stem and progenitor cells in health and vascular disease. 2009 Microcirculation pmid:19479622
Sim-Selley LJ et al. Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS. 2009 J. Neurochem. pmid:19493165
Taniguchi K et al. Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. 2009 Cancer Sci. pmid:19493272
O'Brien N et al. Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies. 2009 J. Lipid Res. pmid:19509417
Serebrov VY et al. Functional activity of sphingomyelin cycle in rat liver in chronic toxic hepatitis. 2008 Bull. Exp. Biol. Med. pmid:19513367
Minamitani C et al. Involvement of Rho-kinase in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts. 2009 Int. J. Mol. Med. pmid:19513538
Liu X et al. Effect of sphingosine 1-phosphate on morphological and functional responses in endothelia and venules after scalding injury. 2009 Burns pmid:19520517
Tokumura A et al. Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis. 2009 Int J Med Sci pmid:19521548
Okajima F et al. [Role of S1P in the lipoprotein-induced actions and their signaling mechanism]. 2009 Seikagaku pmid:19522297
Kobayashi N et al. Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. 2009 J. Biol. Chem. pmid:19531471
Pyne NJ et al. New aspects of sphingosine 1-phosphate signaling in mammalian cells. 2009 Adv. Enzyme Regul. pmid:19534035
Price MM et al. Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors. 2009 FASEB J. pmid:19535686
Gibbs TC et al. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells. 2009 Prostate pmid:19536794
Voelkel NF and Spiegel S Why is effective treatment of asthma so difficult? An integrated systems biology hypothesis of asthma. 2009 Nov-Dec Immunol. Cell Biol. pmid:19546879
Herr B et al. The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor-1alpha in macrophages via sphingosine-1-phosphate and transforming growth factor-beta. 2009 Blood pmid:19549990
Roviezzo F et al. Systemic administration of sphingosine-1-phosphate increases bronchial hyperresponsiveness in the mouse. 2010 Am. J. Respir. Cell Mol. Biol. pmid:19556602
Nixon GF Sphingolipids in inflammation: pathological implications and potential therapeutic targets. 2009 Br. J. Pharmacol. pmid:19563535
Natsume H et al. (-)-Epigallocatechin gallate attenuates the induction of HSP27 stimulated by sphingosine 1-phosphate via suppression of phosphatidylinositol 3-kinase/Akt pathway in osteoblasts. 2009 Int. J. Mol. Med. pmid:19578793
Daum G et al. Sphingosine 1-phosphate: a regulator of arterial lesions. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19592471
Kimber I et al. Langerhans cell migration: not necessarily always at the center of the skin sensitization universe. 2009 J. Invest. Dermatol. pmid:19603050
Camerer E et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. 2009 J. Clin. Invest. pmid:19603543
Scott EA et al. Modular scaffolds assembled around living cells using poly(ethylene glycol) microspheres with macroporation via a non-cytotoxic porogen. 2010 Acta Biomater pmid:19607945
Grabski AD et al. Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19608972
Syuto T et al. Mammalian Diaphanous (mDia) may be involved in the signal transduction of sphingosine-1-phosphate on developing actin stress fiber of human fibroblasts. 2009 Jul-Aug Wound Repair Regen pmid:19614924
Weigert A et al. Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype. 2009 Int. J. Cancer pmid:19618460
Ohno Y et al. Palmitoylation of the sphingosine 1-phosphate receptor S1P is involved in its signaling functions and internalization. 2009 Genes Cells pmid:19619245
Florey O and Haskard DO Sphingosine 1-phosphate enhances Fc gamma receptor-mediated neutrophil activation and recruitment under flow conditions. 2009 J. Immunol. pmid:19620297
Weigert A et al. Regulation of macrophage function by sphingosine-1-phosphate. 2009 Immunobiology pmid:19625101
Rütti S et al. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. 2009 Endocrinology pmid:19628574
Morris AJ et al. Regulation of blood and vascular cell function by bioactive lysophospholipids. 2009 J. Thromb. Haemost. pmid:19630765
Jung ID et al. FcepsilonRI-mediated mast cell migration: signaling pathways and dependence on cytosolic free Ca2+ concentration. 2009 Cell. Signal. pmid:19632319
Martin JL et al. Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. 2009 J. Biol. Chem. pmid:19633297
Trifilieff A et al. Role of sphingosine-1-phosphate (S1P) and the S1P(2) receptor in allergen-induced, mast cell-dependent contraction of rat lung parenchymal strips. 2009 Naunyn Schmiedebergs Arch. Pharmacol. pmid:19636535
Wacker BK et al. Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2. 2009 Stroke pmid:19644058
Hernandez F et al. Local effects of the sphingosine 1-phosphate on prostaglandin F2alpha-induced luteolysis in the pregnant rat. 2009 Mol. Reprod. Dev. pmid:19645054
Vessey DA et al. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. 2009 Am. J. Physiol. Heart Circ. Physiol. pmid:19648253
Ito S et al. Actin cytoskeleton regulates stretch-activated Ca2+ influx in human pulmonary microvascular endothelial cells. 2010 Am. J. Respir. Cell Mol. Biol. pmid:19648475
Kim CH Reining in FoxP3(+) regulatory T cells by the sphingosine 1-phosphate-S1P1 axis. 2009 Immunol. Cell Biol. pmid:19652661
Sarai K et al. Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins. 2009 Am. J. Physiol., Cell Physiol. pmid:19657053
Ren S et al. Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression. 2009 Kidney Int. pmid:19657322
Rapizzi E et al. Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor. 2009 Cell. Mol. Life Sci. pmid:19662499
Haberberger RV et al. Role of sphingosine kinase 1 in allergen-induced pulmonary vascular remodeling and hyperresponsiveness. 2009 J. Allergy Clin. Immunol. pmid:19665772
Pasquaré SJ et al. Age-related changes in the metabolization of phosphatidic acid in rat cerebral cortex synaptosomes. 2009 Arch. Biochem. Biophys. pmid:19691145
Huang YL et al. Tyrosine sulphation of sphingosine 1-phosphate 1 (S1P1) is required for S1P-mediated cell migration in primary cultures of human umbilical vein endothelial cells. 2009 J. Biochem. pmid:19692429
Antoon JW et al. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells. 2009 J. Med. Chem. pmid:19694470
Zhao YD et al. Bone marrow progenitor cells induce endothelial adherens junction integrity by sphingosine-1-phosphate-mediated Rac1 and Cdc42 signaling. 2009 Circ. Res. pmid:19696411
Yamamura T [Molecular target drug development for curing multiple sclerosis]. 2009 Brain Nerve pmid:19697881
Frias MA et al. Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis. 2010 Cardiovasc. Res. pmid:19700468
Francis-Goforth KN et al. Normalization of diabetic wound healing. 2010 Surgery pmid:19703697
Igarashi J et al. Transforming growth factor-beta1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells. 2009 Am. J. Physiol., Cell Physiol. pmid:19710365
Stamer WD et al. Sphingosine-1-phosphate effects on the inner wall of Schlemm's canal and outflow facility in perfused human eyes. 2009 Exp. Eye Res. pmid:19715693
García-Pacios M et al. Sphingosine-1-phosphate as an amphipathic metabolite: its properties in aqueous and membrane environments. 2009 Biophys. J. pmid:19720028
Czech B et al. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. 2009 Biochem. Biophys. Res. Commun. pmid:19720050
Knapp M et al. Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction. 2009 Med. Sci. Monit. pmid:19721401